Intuitive Surgical 

€435.8
1134
-€6.55-1.48% Friday 15:30

統計

當日最高
-
當日最低
-
52週最高
-
52週最低
-
成交量
-
平均成交量
-
市值
-
市盈率
-
股息收益率
-
股息
-

即將到來

收益

17Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
1.2
1.39
1.59
1.78
預期每股收益
1.641381
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 IUI1.XETRA 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Show more...
首席執行官
Dr. Gary S. Guthart Ph.D.
員工
9793
國家
United States
ISIN
US46120E6023
WKN
000888024

上市公司